OFIX: Orthofix Medical Forecast Levels Chart

Corporate company logo of Orthofix International (OFIX)

Orthofix Medical Inc. (OFIX) generates revenue through the sale of orthopedic instruments, bone stimulation systems, and spinal implants. Digital rehabilitation monitoring services provide additional growth, as they scale more efficiently than physical equipment. The company's price evolution reflects a consensus forecast of 10.00. The business is currently focusing on the digital transformation of surgery and the optimization of supply chains following a major merger to increase profitability.

Orthofix Medical (OFIX): Consensus Target from 07/04/2022 to 11/12/2026
Core merchandise of Orthofix Medical

The consensus forecast determines the fair value of an asset through the averaged estimates of professional analysts. This metric filters out market noise, revealing the long-term fundamental trend of the business value. By analyzing the consensus forecast indicator for the stock, an investor assesses the degree of the security's undervaluation. The trend line reflects market confidence in the effective implementation of ESG standards within the production of Orthofix Medical Inc. (OFIX). Strict bioethical control and the greening of factories directly impact the calculated attractiveness of the company.

Competing companies

BSX - Average Forecast Price|Analyst Consensus Forecast EW (Edwards Lifesciences Corporation)|RMD (ResMed Inc) - Forecast Levels Chart|OmniPod - Analyst Consensus Forecast|Analyst Median Target Zimmer Biomet Corp ZBH|COO (The Cooper Companies) - Consensus Target|Broker Consensus Forecast ALGN|Price Target Chart Globus Medical|TransMedics (TMDX) - Analyst Median Target|Price Target Chart ATEC Spine (ATEC)|AORT: Forecast Levels Chart|Analyst Consensus Forecast ENOV (Enovis Corporation)|integralife.com (IART) - Average Forecast Price|Establishment Labs Holdings Inc. - Analyst Consensus Forecast|Beta Bionics, Inc. (BBNX) - Consensus Target|IRMD: Analyst Consensus Forecast|EMBC - Analyst Median Target|TNDM (Tandem Diabetes Care) - Analyst Consensus Forecast|Analyst Consensus Forecast axogeninc.com|Price Target Chart SI-BONE (SIBN)|Price Target Chart BVS (Bioventus Inc)|Analyst Consensus Forecast KIDS (OrthoPediatrics)|Analyst Median Target Treace Corp (TMCI)|SRTA: Consensus Target|Forecast Levels Chart CARL|RXST: Analyst Consensus Forecast|Average Forecast Price ClearPoint Neuro (CLPT)|STXS (Stereotaxis Corp) - Analyst Consensus Forecast|Broker Consensus Forecast STIM (Neuronetics, Inc)|Consensus Target SGHT (Sight Sciences, Inc.)|OBIO (Orchestra BioMed Inc.) - Fair Value Consensus|Price Target Chart Anika Therapeutics, Inc. ANIK|NSPR - Consensus Target|Jin Medical International Ltd - Analyst Consensus Forecast|Average Forecast Price Vivani Medical, Inc.|XTNT: Analyst Consensus Forecast|Broker Consensus Forecast NMTC|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Myomo Inc. (MYO) - Analyst Median Target|Analyst Consensus Forecast COCH|Consensus Target Vivos Therapeutics Inc VVOS|Analyst Consensus Forecast NVNO (enVVeno Medical)|Analyst Consensus Forecast Sintx Technologies Inc SINT|TNON - Price Target Chart|LFWD: Price Target Chart|AMIX (autonomix.com) - Consensus Target|INVO Fertility Corp - Fair Value Consensus|BBLG (Bone Biologics) - Analyst Consensus Forecast|Average Forecast Price axonics.com AXNX|Price Target Chart BIOLASE (BIOL)|dynatronics.com (DYNT) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO